Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

1.

Association of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status with total choline concentration and tumor volume in breast cancer patients: an MRI and in vivo proton MRS study.

Sah RG, Sharma U, Parshad R, Seenu V, Mathur SR, Jagannathan NR.

Magn Reson Med. 2012 Oct;68(4):1039-47. doi: 10.1002/mrm.24117. Epub 2011 Dec 28.

PMID:
22213087
[PubMed - indexed for MEDLINE]
2.

In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.

Sardanelli F, Fausto A, Di Leo G, de Nijs R, Vorbuchner M, Podo F.

AJR Am J Roentgenol. 2009 Jun;192(6):1608-17. doi: 10.2214/AJR.07.3521.

PMID:
19457825
[PubMed - indexed for MEDLINE]
3.

Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.

Suppiah S, Rahmat K, Mohd-Shah MN, Azlan CA, Tan LK, Aziz YF, Vijayananthan A, Wui AL, Yip CH.

Clin Radiol. 2013 Sep;68(9):e502-10. doi: 10.1016/j.crad.2013.04.002. Epub 2013 May 23.

PMID:
23706826
[PubMed - indexed for MEDLINE]
4.

Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS.

Chen JH, Mehta RS, Baek HM, Nie K, Liu H, Lin MQ, Yu HJ, Nalcioglu O, Su MY.

NMR Biomed. 2011 Apr;24(3):316-24. doi: 10.1002/nbm.1595. Epub 2010 Sep 22.

PMID:
20862660
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

1H MR spectroscopy of invasive ductal carcinoma: correlations with FDG PET and histologic prognostic factors.

Tozaki M, Hoshi K.

AJR Am J Roentgenol. 2010 May;194(5):1384-90. doi: 10.2214/AJR.09.3431.

PMID:
20410429
[PubMed - indexed for MEDLINE]
6.

The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004.

Brown M, Tsodikov A, Bauer KR, Parise CA, Caggiano V.

Cancer. 2008 Feb 15;112(4):737-47. doi: 10.1002/cncr.23243.

PMID:
18189290
[PubMed - indexed for MEDLINE]
Free Article
8.

In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response.

Bathen TF, Heldahl MG, Sitter B, Vettukattil R, Bofin A, Lundgren S, Gribbestad IS.

MAGMA. 2011 Dec;24(6):347-57. doi: 10.1007/s10334-011-0280-9. Epub 2011 Sep 10.

PMID:
21909791
[PubMed - indexed for MEDLINE]
9.

Estrogen receptor and breast MR imaging features: a correlation study.

Chen JH, Baek HM, Nalcioglu O, Su MY.

J Magn Reson Imaging. 2008 Apr;27(4):825-33. doi: 10.1002/jmri.21330.

PMID:
18383260
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Neoadjuvant chemotherapy of breast cancer: tumor markers as predictors of pathologic response, recurrence, and survival.

Precht LM, Lowe KA, Atwood M, Beatty JD.

Breast J. 2010 Jul-Aug;16(4):362-8. doi: 10.1111/j.1524-4741.2010.00935.x. Epub 2010 Apr 28.

PMID:
20443786
[PubMed - indexed for MEDLINE]
11.

HR-MAS MR spectroscopy of breast cancer tissue obtained with core needle biopsy: correlation with prognostic factors.

Choi JS, Baek HM, Kim S, Kim MJ, Youk JH, Moon HJ, Kim EK, Han KH, Kim DH, Kim SI, Koo JS.

PLoS One. 2012;7(12):e51712. doi: 10.1371/journal.pone.0051712. Epub 2012 Dec 14.

PMID:
23272149
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Diagnostic value of breast proton magnetic resonance spectroscopy at 1.5T in different histopathological types.

Baek HM.

ScientificWorldJournal. 2012;2012:508295. doi: 10.1100/2012/508295. Epub 2012 May 1.

PMID:
22654620
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Choline as a biomarker for cell proliferation: do the results from proton MR spectroscopy show difference between HER2/neu positive and negative breast cancers?

Baek HM, Chen JH, Nalcioglu O, Su MY.

Int J Cancer. 2008 Sep 1;123(5):1219-21. doi: 10.1002/ijc.23552. No abstract available.

PMID:
18546272
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Evaluation of breast cancer using proton MR spectroscopy: total choline peak integral and signal-to-noise ratio as prognostic indicators.

Shin HJ, Baek HM, Cha JH, Kim HH.

AJR Am J Roentgenol. 2012 May;198(5):W488-97. doi: 10.2214/AJR.11.7292.

PMID:
22528931
[PubMed - indexed for MEDLINE]
15.

Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.

Jagannathan NR, Kumar M, Seenu V, Coshic O, Dwivedi SN, Julka PK, Srivastava A, Rath GK.

Br J Cancer. 2001 Apr 20;84(8):1016-22.

PMID:
11308247
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.

Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM.

J Natl Cancer Inst. 2005 Sep 7;97(17):1254-61.

PMID:
16145046
[PubMed - indexed for MEDLINE]
Free Article
17.

Clinical features and survival analysis of T1mic, a, bN0M0 breast cancer.

Li J, Liu X, Tong Z.

Jpn J Clin Oncol. 2012 Jun;42(6):471-6. doi: 10.1093/jjco/hys046. Epub 2012 Apr 3.

PMID:
22493058
[PubMed - indexed for MEDLINE]
Free Article
18.

In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy.

Russo F, Mazzetti S, Grignani G, De Rosa G, Aglietta M, Anselmetti GC, Stasi M, Regge D.

Eur Radiol. 2012 May;22(5):1131-9. doi: 10.1007/s00330-011-2350-9. Epub 2011 Dec 4.

PMID:
22138734
[PubMed - indexed for MEDLINE]
19.

Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.

Parise CA, Bauer KR, Brown MM, Caggiano V.

Breast J. 2009 Nov-Dec;15(6):593-602. doi: 10.1111/j.1524-4741.2009.00822.x. Epub 2009 Sep 17.

PMID:
19764994
[PubMed - indexed for MEDLINE]
20.

Correlations between diffusion-weighted imaging and breast cancer biomarkers.

Martincich L, Deantoni V, Bertotto I, Redana S, Kubatzki F, Sarotto I, Rossi V, Liotti M, Ponzone R, Aglietta M, Regge D, Montemurro F.

Eur Radiol. 2012 Jul;22(7):1519-28. doi: 10.1007/s00330-012-2403-8. Epub 2012 Mar 13.

PMID:
22411304
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk